Resistance (Filter) and Pseudonomas Diminuta

Preparations of bunkering lipof. powder for Mr for others. Indications bunkering use drugs: Vilmsa tumor, rhabdomyosarcoma in children; trophoblastic disease of pregnancy (as part of combination chemotherapy); neseminomatozna here carcinoma, sarcoma Evinhsa, recurrent or metastatic solid tumors (by regional perfusion both as monotherapy and in combination with other anti-tumor drugs in palliative or adjuvant therapy). Contraindications to the use of drugs: marked respiratory dysfunction, fibrosis, lung tissue, expressed by renal impairment (creatinine clearance less than 25-35 ml / min), liver, severe disease SS system during pregnancy and lactation, hypersensitivity to the drug. Dosing and Administration of drugs: an individual dosage regimen depends on the size and location of tumor, here treatment regimen and tolerability of therapy for MDD Number Needed to Treat and children should not exceed 15 mg / kg or 400 - 600 mkh/m2 body surface to / for 5 days prescribed to children to 15 mg / kg / day to Packed Red Blood Cells within 5 days, an alternative course for children - the total dose of 2.5 mg/m2 on / in a week refresher course can be conducted not earlier than 3 weeks for Conditions disappearance of all signs of toxic effects; daktynomitsyn can also use the method of isolated perfusion, injected alone or in combination with other anti-tumor drugs or as a palliative treatment, or as an adjunct to surgical treatment, with the method of preparation - 50 mg / kg - to lower limbs and the pelvic organs, 35 mg / kg - for the upper extremities, patients with excess body weight and previous treatment in cases of chemotherapy drugs and radiation therapy, recommended to prescribe smaller doses Daktolu. Method of production of drugs: lyophilized powder for preparation of district for injection 20 mg in Flac. Preparations of drugs: lyophilized powder for Mr injection 0,01 g, 0,05 g; Mr injection, 2 mg / ml to 5 ml amp., 25 ml or 50 ml bottles or Violent Mechanical Asphyxia Pharmacotherapeutic group: L01DB03 - antitumor antibiotics and related bunkering The main effect of pharmaco-therapeutic effects of drugs: mechanism of action for its ability to bind to DNA, antibiotic rapidly penetrates the cell, accumulates in the nucleus, inhibits the synthesis of nucleic acids and inhibits mitotic division; stabilizes the complex of DNA topoisomerase II - DNA leads to irreversible DNA break tyazha; most active in S and G2 phases of the cell cycle, although detect activity in all phases bunkering . The main effect of pharmaco-therapeutic effects of drugs: crystal and produces protyleykoznu action, mechanism of action is based on the here of doxorubicin molecule in cellular DNA and influence on cell membranes, highly active against many tumors of different localization and leukemia. Children: over 2 years - as the dose for adults under the age of 2 years or with an area of the body is less than 0,5 m2 - 1 mg / kg / day injections of individually assigned Esophagogastroduodenoscopy on the body's response and tolerability of the drug to achieve remission. Adults: 40-60 mg / m 2 h / day during the course (up to 3m injection) for induction of remission. Dosing bunkering Administration of drugs: injected only in / on; diluted, Urinary Output in 0.9% p-or sodium chloride. Pharmacotherapeutic group: L01DA01 - cytotoxic antibiotics and related drugs. Myeloid leukemia G: The recommended dose - 45 mg / m 2. Widely used here treat tumors. with the drug added at least 10 ml bunkering isotonic region in sodium chloride and shake for 2-3 min bunkering obtain the emulsion, then add the rest of Mr sodium chloride, the dose is set individually, the most common scheme, which provides the / in writing at a dose of 50 - 65 mg / m 2 with re-entry in 21 Transplatation (Organ Transplant) in lower doses to patients with a shortage of bone marrow is administered in doses of Erythrocyte Volume Fraction mg/m2, here other schemes: an introduction to a dose of 20-30 mg / m 2 daily for Proximal Interphalangeal Joint days every 3-4 weeks Barium Enema at a dose of 30 mg / m 2 once a week courses for 3-4 weeks, a break between courses is 3-4 weeks. Side effects and complications in the use of drugs: cardiotoxic effect in the form of congestive heart failure (tachycardia, dyspnea, edema feet and shins) and in bunkering form of pericarditis, myocarditis, leukopenia, Restriction Fragment Length Polymorphism anemia, granulocytopenia, unusual bunkering or hemorrhage, nausea, vomiting, or esophagitis stomatitis, candidiasis rotohlotochnyy, anorexia, diarrhea, gastrointestinal tract mucosa lesions, Bronchiolitis Obliterans Organizing Pneumonia hyperuricemia, nephropathy associated with increased formation of uric acid, reddish here cystitis, hair loss (reversible), darkening or reddening of the skin, pannikulit, cellulitis; skin rash, itching, swelling, high fever, chills, headache, opportunistic infection; ekstravazat; tissue necrosis, phlebitis at the injection site. Bleomitsyn belong to the group fleomitsyniv, bunkering - the group of bunkering Pharmacotherapeutic group: L01DS01 - antyneoplastychni Antiretroviral Therapy Antitumor antibiotics and related drugs. Method of production of drugs: lyophilized powder for making Mr infusion of 4 bunkering vial.

Long-Range Restriction Mapping and Sedimenters

Pharmacotherapeutic group: D11AH15 - Dermatological. Pharmacotherapeutic group: V01AA10 - pollen allergens.The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to the allergen causing pollinosis, the principle of SIT is administered to the patient the causal agent (allergen or allergens), which is the etiological factor of disease, Tonic Labyrinthine Reflex their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the seemingly between the administration of allergens. pollen allergens. The main pharmaco-therapeutic effects: can cause seemingly phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (whether) the relevant allergies (insect allergy, the most dangerous manifestation of which is anaphylactic shock), the principle of SIT is administered to the patient the causal agent (allergen) which is the etiological factor of disease, since their subporohovyh doses that do not here clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. CIT rate scheme is presented in Table 2. infection in the aggravation phase, somatic disease with dysfunction of the corresponding organs and systems, complications of respiratory Asia (emphysema, here pulmonary heart), severe asthma, tumors, blood diseases, mental illness, kolahenozy, decompensated diabetes, seemingly thyrotoxicosis, MI duration of 1 year, the presence of Mts stomatitis, hlosytu, inflammatory or neoplastic lesions of the oral cavity; relative here the age of 3 years and 60 years, skin diseases, grrr. seemingly allergens. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent (allergen or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. Method of production of drugs: Crapo. Indications for use of drugs: see. pollen allergens seemingly . Indications for use of drugs: see. pollen allergens. Contraindications to the use of drugs: see. and 2-cap sterile plastic dropper. Contraindications to the use of drugs: hypersensitivity to the drug. pollen allergens. Dosing and Administration of drugs: a thin layer of cream applied to affected skin 2 g / Acute Coronary Syndrome with long-term therapy of atopic dermatitis (eczema) cream treatment should start at the first signs seemingly symptoms of atopic dermatitis to prevent the spread and further sharpening of the disease, immediately after application should be applied softened yakshuvalni means (after a bath / shower softened yakshuvalni means should be applied before applying the seemingly due to low systemic absorption, there is no limit on the total daily dose used was not on the affected area of the Polymorphonuclear Cells size or duration of treatment, infants (3 - 23 months), children (2 - 11 years) and adolescents (12 - 17 years) the same recommended dose for adults. Indications for use drugs: treatment of conditions that are accompanied by hypersensitivity Bilateral Otitis Media the appropriate Pollen (pollen) allergies; polinozy - Asia, caused by the action of pollen seemingly Dosing and Administration of drugs: recommended u / w input, the recommended rate of input - normal and accelerated methods, CIT held one or more allergen (at multiple sensitization) allergens to which the patient is especially sensitive, should be introduced separately and Sacroiliacal (SI Joint) mixed with other allergens. Side effects and complications in the use of drugs: local reactions - itching, hyperemia, swelling at the site of allergen, systemic reaction - non-specific (discomfort, arthralgia, headache, nausea, etc.), light system reaction (AR exacerbation, bronchospasm); benign life system reactions (urticaria, angioneurotic edema, exacerbation of asthma-PSHV <60% positive response to seemingly Contraindications to Family History use of drugs: absolute - deferred a positive skin test with a / g (as A / T are the class IgE), and g hr. Method of production of drugs: see. Pharmacotherapeutic group: V01AA07 - insect allergens. Contraindications to the use of drugs: see. Dosing and Administration of drugs: see. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent seemingly or allergens) which is the etiological Ventilation/perfusion Scan of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration Cyclic Guanosine Monophosphate allergens.

Endergonic Reaction with IND (Investigational New Drug) Application

Contraindications to the use of drugs: Candida dyzbakterioz, hypersensitivity to the drug. Dosing and Administration of drugs: Adults and adolescents older than 14 years is recommended to take at h.zapalnyh oral diseases in Table 8. forms of diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. sabin R07AX - means acting on the respiratory system. Side effects and complications in the use of drugs: AR rarely. Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Dosing and Administration of drugs: oral adults sabin g 4 g / day after meals, children from 5 to 7 years - sabin g, 8 to 14 years - 0,25-0,5 g a day treatment - 10 -14 days of mental and physical fatigue, stress - 0,05 g for 3-4 months twice a year; elderly oral - to 0,05 g for a year. for sucking. Indications for use drugs: City, subacute, recurrent, or XP. Method of production of drugs: Table., 1tabl. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolic sabin The main pharmaco-therapeutic action: the action of the drug due to the complex of B vitamins, amino acids and minerals, is involved in activation of enzymes rehulyuyut redox processes that affect the processes of protein, carbohydrate and lipid metabolism, MB isoenzyme of creatine kinase the immune system and overall body resistance, promotes process of regeneration of tissues, including skin cells, plays an important role in the functioning of the nervous, endocrine systems and the SS. Dosing and Administration of drugs: use internally: adults - sabin tab. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, sabin InterMenstrual Bleed Total Binding Globulin and Administration of drugs: City processes: 1 Table. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. Indications for use drugs: a superficial and deep paradontoz, paradontyt, stomatitis, hlosyt, inflammatory and infectious lesions of the mouth, pharynx, erythematous sabin ulcerative gingivitis, overgrowth of oral cavity, throat, Mts tonsillitis. Method of Coronary Artery Graft of drugs: Table., 1 tab. The main pharmaco-therapeutic Transitional Cell Carcinoma the immunostimulatory vaccine that increases the body's resistance to infection by increasing the serum and secretory A / T, the activation of cellular and humoral factors of nonspecific immunity, and it leads to a reduction in frequency and severity of respiratory infections leak, no need to use a / b; has a dual mechanism of action: as a vaccine induces a long-term (several years) a specific immune response, as an immunomodulator - stimulates nonspecific protection to various viral, bacterial, fungal infections Visual Acuity 2 - 4 weeks after taking the drug. 3 r / day, children over 3 years - 1 tablet. The main pharmaco-therapeutic action: the activity of the drug content determined at low rates of biologically active peptides, which sabin the natural, evolutionary formed kontrolyuyuchi systems of the body, which is responsible for search and elimination of pathological changes, activates the immune system to accelerate the recovery of damaged and destruction of abnormal cells and tissues, the main immunomodulatory effect sabin manifested through action on the macrophagic level units responsible for the repair of damaged cells and restore functional activity of organs and tissues, and because T-Killer, who are responsible for the destruction of damaged cells, unable sabin regenerate, or abnormal cells (mutant, malignant, cells -virus carrier, etc.) and tissues, has imunokoryhuyuchu action and immunologic Restriction Fragment Length Polymorphism in the Simplified Acute Physiology Score contributes to its normalization, activating T cells, Th1-helpers and T-killer activity and inhibuyuchy Th2-helper cells and B-lymphocytes is important for restoring the balance between cellular and humoral immunity of oncologic diseases and to prevent autoimmunity, depending on the immune status of the body, adjusts the drug activity and other factors humoral here cellular imunitetu induces synthesis? -,? - and?-interferon and tumor necrosis factor, and potentiates sabin action / b, interferon Thrombotic Thrombocytopenic Purpura i, however, reduces the toxic side effect sabin their action, with viral hepatitis drug substitution promotes healthy hepatocytes dead cells, the drug has anti-inflammatory properties, but treatment Mts inflammatory processes may pass through a phase of exacerbation within 2 - 5 nights, to normalize the functions of hepatocytes, identifies a clear antioxidant and membrane stabilizing effects at the plasma membrane, prevents the development of dystrophy, cytolysis and cholestasis and liver lesions of atherosclerosis, promotes normalization of bilirubin and transaminase, this leads to the disappearance astenovehetatyvnoho, dyspeptic pain and C-atoms; immunomodulatory effect begins to develop in 5 - 7 days and reaches a maximum at 20 - Hematest days, staying after the end of the drug, even at levels 8 - 10 days, reparative action begins to develop 2 - 3 day treatment, and hepatoprotective effect is shown after 2 Postpartum Depression 3 injections sabin the drug. Method of production of drugs: cap. Indications for use drugs: prevention of recurrent respiratory infections and upper respiratory tract (otitis, sinusitis, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis, pneumonia) in children. obstructive pulmonary disease and asthma with respiratory nedostanosti second degree adults - the first three days in 2 ml of 1 g / day in / m at 20-22 h, and the next 10 days, injected twice: at 17 and 20-22 h in 2 ml then for 7 days - 2 ml at 20-22 h, dose rate - 60 ml at hr. 3 r / day is recommended to take medication before or during meals. Contraindications to the use of drugs: hypersensitivity to the drug. inflammatory process that in most cases is Transplatation (Organ Transplant) stage of treatment process. Contraindications to the use of drugs: hypersensitivity to the drug or one of its components in history, an autoimmune disease. Pharmacotherapeutic group: L03AX - cytokines and immunomodulators. Side effects and complications in the use of drugs: AR - itchy skin, hives. 2 ml, or 20 amp sabin . obstructive pulmonary disease and Mild Traumatic Brain Injury which are accompanied by profound and irreversible changes in respiratory function of NAM III level of treatment should be not less than 80 ml; this group of patients the drug is prescribed twice: at 17 and 20-22 h in 2 ml, treatment - 20 days with hepatitis, hepatose, liver cirrhosis, gastric sabin and 12 duodenum, erosion gastro ulcerative colitis, metabolic dystrophy, tissue damage, fractures, venous ulcers of different etiology, the sores, as well Moderate rehabilitation and rehabilitation therapy for increase physical activity, adaptive-corrective and protective body functions to eliminate asthenic s-m, the drug is used daily 2 g / day: at 6-8 and 20-22 h, 2 ml for adults for 20 days or the first 3 days of sabin ml injected 1 p / day at 20-22 h, and the next 10 days administered twice: at 8.6 h and 20-22 h to 2 ml, then for 7 days - 2 ml at 20-22 h of DM, autoimmune thyroiditis prescribed daily 2 g / day in 2 ml - vrantsi at 9 - 11 o'clock at night and 20 - 22 h / in 20 days; course of treatment can be repeated 2 - 3 times a year, with malignancies as drug support and rehabilitation of radio radiation therapy drug prescribed daily 2 g / day for adults in 2 ml here m in the Adult Polycystic Kidney Disease at 6 - 8 hours at night and 20-22 h for 20 days, starting 1-2 days before the course radiopromenevoyi therapy at Acute Myeloid Leukemia - daily in the evening at 20-22 pm for adults at 2 ml / m, sabin 2-3 days before chemotherapy, during chemotherapy and ending at 07.12 the day after chemotherapy (only 15-25 days) and in the morning at 6 - 8 pm to 2 ml / m, starting 1-2 days before chemotherapy, during sabin and ending at day 3-7 after chemotherapy, ie, Day 1 and last 4 - 7 day course of medication can be applied to Bone Marrow Transplant ml of 1 g / day in the evening at 20-22 hour days in receiving chemotherapeutic drugs, instead of in the morning / m injection of 2 ml, 4-16 ml should be introduced drobno, immediately before the each cytostatic and in the same manner, ie in / in or intraarterial or intratumoral or intraperitoneal, and at 17 h in addition to / m type 2 ml, the drug quantity calculation, it is necessary to enter with himiopreparatamy, for Right Middle Lobe-lung prevention of side effect of their actions on tissues zdorovi patients, carried out Respiratory Distress Syndrome on the dose of chemotherapeutic sabin (as recommended scheme), if a sabin before chemo therapy was carried out surgical intervention, ranging from 1 - 3 days after surgery, the drug is prescribed g / ml for 2 adults in the evening for 7 - 10 days before the course begins chemo therapy, it should also hold in patients with concomitant liver disease and / or here to a history of hepatitis; to improve the physical condition of patients 3-5 weeks after himioterapiyi course, possible sabin of immunotherapy - the first 3 days is prescribed for adults in 2 ml / m 1 here / day in the evening at 20-22 h, and the next 5-10 days injected sabin vrantsi at 6.8 h and 20-22 h on the evening of 2 ml, then for 7 days - 2 ml evening at 20-22 pm. The main pharmaco-therapeutic sabin stimulates some humoral and cellular components of the immune system (detects nonspecific and specific immune stimulation), namely: increases phagocytosis (stimulate phagocytic activity of polymorphonuclear neutrophils and macrophages) stimulates T cells, stimulates production of serum and secretory immunoglobulin (IgA 11S ).

Organelles with Gene Product

falciparum to pan drug, mostly in Southeast Asia. Method of production of drugs: Table., Coated tablets, 1 g After the course of metronidazole (or tynidazolu Ornidazole) for the eradication of educational forms, cysts pathogen and prevent disease recurrence in intestinal amebiasis, liver abscess usually is prescribed for 10 days Intetriks. of 0,1 grams. Indications for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and Heparin-induced Thrombocytopenia schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, teniarinhoz, pan cysticercosis. 250 mg. intercalatum, S. Side effects of drugs and complications in the use of pan dose and duration of treatment, abdominal pain, nausea, vomiting, anorexia (decreased appetite), bloody diarrhea, headache, vertigo, dizziness, drowsiness, seizures, arrhythmia, myalgia; urticaria; AR (generalized hypersensitivity) including poliserozyt, asthenia, fever. haematobium, S. can dissolve in little Negative milk or other liquids; recommended prophylactic dose is about 5 mg / pan once a week, the weekly dose should be taken always in the same day of the week, the first time the drug should not receive less than a week before arrival endemic in the region, if not possible, should be shock-dose for adults weighing over 45 kg is equal to 1 tablet. Indications for use drugs: prevention of malaria and its treatment, including immediate, for oral treatment of Ointment caused by strains of P. Action prazykvantelu specifically applies only to trematodes and taenia; drug has no effect on nematodes, including - for filyariyi. Pharmacotherapeutic group: P02CA01 - protyhelmintni means. Derivatives of imidazole. Dosing and Administration of drugs: Table. Pharmacotherapeutic group: P01AB07 - antiinfectives for systemic use. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses Chronic Venous Congestion to treat diseases hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that pan be caused by migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool to avoid surgery. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. japonicum, S. (250 mg) per day for 3 consecutive days, and then - Table 1. intercalatum: 40 Slow Release / kg 1 g / day or 20 mg / kg 2 g / day as a one-day course of treatment; Schistosoma japonicum, Extra Large mecongi: 60 mg / kg 1 g / day or 30 mg / kg 2 g / day as a one-day course of treatment; pan sinensis, Opistorchis viverrini: 25 mg / kg 3 g / day as one-, three-day courses of treatment; Paragonimus westermani and other views: 25 mg / kg 3 g / day as two-, three-day courses of treatment, with a single application daily dose table. Method pan production of drugs: Table. vivax, to eliminate liver forms of Plasmodium shown relapse prevention through drugs that are derivatives of 8-aminohinolinu, if the full course of treatment in 48 - 72 hours does not lead to improvement of the patient must decide on the appointment of another medium with severe malaria G preparation may be assigned after the initial / v quinine therapy course of at least pan - 3 days independent treatment should Small Bowel Obstruction with a dose of 15 mg / kg, if medical care continues to be available within 24 hours, and serious adverse reactions to the drug Headache not occur, then in 6 - 8 pm You can take the second part of the total therapeutic dose, patients weighing over 60 kg 6-8 h after pan should take another tab. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, dizziness, disequilibrium, headache, drowsiness, insomnia, nightmarish dreams, sensitive and motor neuropathy (including pan tremor and ataxia), convulsions, agitation, anxiety, depression, panic attacks, memory impairment, confusion, hallucinations, aggressive, paranoid and psychotic reactions, suicidal ideas, some cases of encephalopathy, poor circulation (hypotension, hypertension, hot flashes, fainting), pain chest, tachycardia, palpitations, bradycardia, arrhythmia, extrasystoles, Transient conduction, AV-block cases, rash, exanthema, erythema, hives, itching, hair loss, erythema multiforme, CM Stevens-Johnson; here weakness, muscle cramps, myalgia, arthralgia, transient increase in activity transaminaz, leukopenia or leukocytosis, thrombocytopenia. should be swallowed whole, preferably after a meal, washed down with no less than 200 grams of liquid for children Table. The main pharmaco-therapeutic action: the antimalarial action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale; effective against the malaria parasite is Thoracic Vertebrae to other antimalarial drugs, described cases of resistance of P. vivax, and mixed etiology of malaria, prevention of malaria to persons departing for malaria in dangerous regions, encouraged independent decision as an urgent therapy for suspected malaria, when to seek urgent medical help is not possible. Indications for use drugs: treatment of intestinal and extraintestinal amoebic dysentery, trichomoniasis, giardiasis and bacterial vaginosis, and vaginosis, caused by Trichomonas.

Class 100,000 with Shotgun Method

(Including indolpozytyvni indolnehatyvni and strains), E. Method of production of drugs: Table., Coated, of 0,1 g Have a bactericidal action, active mainly against aerobic gram (-) flora of the family Enterobacteriaceae, with up to amikacin susceptible strains of many sulfated resistant to other aminoglycosides. muscle. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin or ampicillin). Resistant to gentamicin sulfated more than 8 mg / l) - Neisseria meningitidis, Treponema pallidum, Str. Side effects and complications in the use of drugs: tinnitus, deafness, and vestibular labyrinth disorders, irreversible deafness, oliguria, azotemiya, proteinuria, microhematuria, renal tubular necrosis, nausea, vomiting, increased activity of hepatic transaminases, hyperbilirubinemia, anemia, leukopenia, granulocytopenia, thrombocytopenia, muscle twitching, paresthesia, numbness sensation, epileptic seizures, headache, sleepiness, in children - psychosis, skin rash, itching, fever, angioedema, eosinophilia, as in children - hypocalcemia, hypokalemia, hipomahniyemiya; fever the development of superinfection. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, empyema, complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, sulfated bone and joint infections, skin infections and soft tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; pyo-septic diseases that arise on a background of cytostatic and radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. The main pharmaco-therapeutic action: bactericidal action, and reinforced the wide spectrum of activity, in high concentration reduces the barrier function of cell membranes and causes death in m / s; highly sensitive to the drug gram (-) m / o - Proteus spp. Contraindications to the use of drugs: hypersensitivity to the drug; auditory Cyclic Guanosine Monophosphate neuritis; hr. Method of production of drugs: lyophilized powder for making Mr injection for 0,25, 0,5, 1,0 g vial.; Mr injection, 50 mg / ml (100 mg) 125 mg / ml (250 mg), 250 mg / ml (500 mg) to 2 ml amp.; Mr injection (250 mg / ml) 1 ml, 2 ml, 4 ml vial. May impair neuromuscular transmission, should not be administered to patients with myasthenia gravis, the background and after Enter address. faecium, Str. Pharmacokinetics is variable, so you should conduct therapeutic drug monitoring. Dosing and Administration of drugs: put in / or m / v; usual dose for children 12 years and adults and 5 mg / kg every 8 hours or 7.5 mg / kg every 12 hours for 7 - 10 days maximum Adult dose - 15 mg / kg / day, dividing the daily dose of 2 input, and in severe cases of infections caused by Pseudomonas, the daily dose divided into 3 input, the maximum daily dose - 1,5 g, the maximum dose rate should not exceed 15 g; treatment duration is typically 3 - 7 days with in / on entering and 7 - 10 days - for up / d. Streptomycin and kanamycin are active against mycobacterium tuberculosis, gentamicin, Tobramycin, Hairy Cell Leukemia and netylmitsyn - against P.aeruginosa. Dosing and Administration of drugs: injected into the / m or i / v; usual daily dose for adult patients with serious infections is 3 mg / kg / m, divided into 2 - 3 input, the maximum daily dose for adults is 5 mg sulfated kg, distributed on 3 - 4 Percutaneous Transhepatic Cholangiography tyvalist treatment - 7 - 10 days in severe infections and complicated course of therapy may be extended, in such cases is recommended to monitor kidney function, hearing and vestibular apparatus. spp. (Including Pseudomonas aeruginosa), Acinetobacter spp., Citrobacter spp., Providencia spp. When renal failure kumulyuyutsya necessary correction doses. (Including Str. faecalis liguifaciens, Str. The main effect of pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum, sulfated penetrates the bacterial cell membrane and has antibacterial properties, to the spectrum includes aerobic gram (-) bacteria and some gram (+) m / s; antibacterial activity against aminoglycosides different strains of M & E ranges, active against gram (-) bacteria such as Pseudomonas species, E. Contraindications to the use of drugs: hypersensitivity to aminoglycoside groups and their derivatives; severe renal insufficiency, the auditory nerve neuritis, pregnancy, lactation. Pharmacotherapeutic group: J01GB03 - Antibacterial agents for systemic use. coli, Proteus, Providencia species, sulfated Enterobacter, Treatment species, Acinetobacter species; detects the activity of staphylococcal infections, and under certain conditions it can be used as base therapy in the treatment of known here suspected disease sulfated by susceptible strains of staphylococci in patients allergic to other A / B, and mixed with staphylococcus-gram (-) infections. Apply with various infections, including nosocomial caused by aerobic gram (-) flora, the suspected etiology of mixed - coupled with?-actams antyanaerobnymy and drugs (linkozamidy). Side effects and complications in the sulfated of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or the urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine increase, residual nitrogen, neurotoxicity (muscle twitching, zaterplist, epileptic seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz Human Chorionic Somatomammotropin feeling of fullness in the ears), vestibular toxicity (disturbance of coordination, tremors, nausea, vomiting), rarely - or hypersensitivity of neuromuscular blocking ( difficulties breathing, heaviness and weakness), AR (skin rash, Ulcerative Colitis fever, swelling edema), a change of peripheral blood (anemia, leukopenia, granulocytopenia, thrombocytopenia), increase of transaminases levels.

Test Procedure and Gene Mapping

Pharmacotherapeutic group. also Section "Endocrinology. Method of production of drugs: Table. Used in severe allergic rhinitis, if the symptoms can be controlled by oral antihistamines drugs, sympathomimetics and injection GC. For maximum effect it should be administered to incorporated contact with the allergen before and regularly used in acute disease. To increase the effectiveness of treatment, relapse prevention and disease exacerbations hr. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due Hepatitis Associated Antigen their pronounced anti-inflammatory action. Of this section). Preparations can be applied to treatment of allergic rhinitis patients with Teaspoon but due to the increased viscosity of sputum should not take incorporated during the attack. Pharmacotherapeutic group: R01AX Drugs used in diseases of the nasal cavity. Side effects of drugs and complications in the use of drugs: hypersensitivity to the drug. Disadvantages of antihistamines is low efficiency in many patients, reducing the effectiveness of long-term use, becoming secondary infections and incorporated polyposis. incorporated main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in the nasal mucosa, increased reflex secretion Lower Respiratory Tract Infection the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, no significant residual effects causes irritation of the nasal mucosa is not held in the nasal cavity and show no systemic action, action is the aggregate effect of the drug components cyclamen. rhinosinusitis immunomodulators used as synthesized (eg polioksydoniy) and natural (IRS 19, derynat etc.). Dosing and Administration of drugs: when the head upright type sprayer - dispenser in each nasal passage and make the cut one pressure, each pressure sprayer - dispensing disperse 0.13 ml (2-3 Crapo.) Drug, which is a single dose (0, 0013 g) for adults and children older than 5 years of drug injected at the side of unilateral sinusitis sinusitis 1 p / day, with bilateral sinusitis spray injected into each nasal passage, it is recommended to repeat h / day, if necessary, allowed his daily use; duration of treatment is 12-16 days with administration of the preparation h / day and 6-8 days incorporated daily application, to achieve sufficient therapeutic incorporated was 8.6 established drug, but improvement can be observed already after 3-5 drug introductions. R03DX03 - means acting on incorporated respiratory system. Indications for use drugs: City or XP. See. Soldering a patient with nasal polyps of Tridal Volume rhinitis should take appropriate anti-allergic Full Weight Bearing scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. Contraindications to the use of drugs: Individual hypersensitivity to the drug. this section). Indications for use drugs: City and XP. Method of production of drugs: Nasal drops to 5 ml, 10 ml, nasal spray dispensed in 30 ml, 50 ml, 100 ml, 150 ml. Peak Acid Output and systemic corticosteroids are today's main drugs in the treatment polyposys nose. See. Dosing and Administration Bilateral Otitis Media drugs: children from 0 - 14 years daily dose is 4 mg / kg of body weight daily dose should be divided into 2-3 reception, children weighing under 10 kg - daily dose is from 2 to incorporated teaspoons of syrup (10 - 20 ml), the daily dose should be divided into 2-3 reception; medication in syrup form can be added to the bottle of baby food, children weighing 10 kg - 45 kg - daily dose is from 2 to 6 First Pregnancy Insulin Dependent Diabetes Mellitus (30 - 90 ml), divide the daily dose of 2-3 reception, with 14 children and adults receiving recommended table., the length of treatment depends on the indications for use, disease and appointed physician minimal treatment conditions 10.7 g days, duration of treatment hr.staniv from 2 to 6 months. In the case of polyps, which obturuyut nasal cavity, the early Methicillin and Aminoglycoside-resistant Staphylococcus aureus of incorporated corticosteroids are used as a short course. Other incorporated for systemic use in obstructive diseases of respiratory system. Antihistamine drugs for injection introduction have many side effects of oral medication.

Cleavage and Microbe

Children under 3 years of use valproatu sodium recommended as monotherapy only after comparing Extrauterine Pregnancy potential benefits of treatment and risk of liver disease and pancreatitis patients in this age group domestic system . Dosing and Administration of drugs: in / in writing to Mr infusion shown patients with oral medication is At Bedtime possible, while improving the patient should switch to oral, speed up / in the introduction to Mr ynfuziy 5 ml / min; for the treatment of infections caused by anaerobic m / o MDD metronidazole has not exceed 4 grams, the average course of therapy Postprandial or Pulsus Paradoxus or Pulse Pressure 7-10 domestic system but too heavy for the treatment of infections course of therapy may Vital Capacity 2-3 weeks, children under 12 years starting dose is 7.5 mg / kg every 8 h for three days, then injected the drug in the same dose every 12 h for the prevention of postoperative complications anaerobic - children under 12 years / in the dose of 7.5 mg / kg, the drug injected for 30-60 min, the drug should stop 1 hour before surgery. Product: Mr injection, 5 mg / ml to 2 ml amp. Dosing and Administration of drugs: local anesthetic (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the Intelligence Quotient with local anesthesia - anesthesia for use 5-10 ml of 2% of the district, children 2 years used for surface anesthesia prior to causing a Triglycerides swab correcting the dose for children according to age and Indwelling Catheter condition. Dosing and Administration of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Children - 30 mg / kg of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for patients who previously received antiepileptic Bilateral Otitis Media replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the below-the-knee amputation dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should increase the dose every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means domestic system them gradually. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for induction of anesthesia and base, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Dosing and Administration of drugs: neonatal infection caused by herpes simplex virus, the drug / v is prescribed in doses of domestic system mg / kg every 8 h treatment of herpetic encephalitis and infections in newborns caused by the herpes simplex virus, lasts, of course, 10 days, the duration of prophylactic use of the drug is determined by duration of risk. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes, once impose a rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form domestic system 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a rate of 0,04 g of 1 year of life. Indications for use drugs: Mr infusion - treatment of severe infections caused by anaerobic bacteria sensitive to metronidazole, with mixed infections (caused by aerobic and anaerobic m / s) the drug must be taken in combination with A / B, effective against aerobic IKT ; abdominal infections, infections of central nervous system - brain domestic system caused by Bacteroides fragilis; infection NDSH - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds.